Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Brandner

Showing results (261-270 of 369) with videos related to

Pageof 37
Sort By:
Archives of Pathology & Laboratory Medicine|June 21, 2019
Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer ReportingDavid N Louis, Pieter Wesseling, Sebastian Brandner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2013
Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophyArianna Tucci, Yo-Tsen Liu, Elisabeth Preza, et al.
Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
European Journal of Neurology|September 24, 2022
Surgical hematoma evacuation of cortical intracerebral hemorrhage ≥10 ml reduces risk of subsequent epilepsy by more than 70%: A retrospective monocenter studyTamara M Welte, Josephine Steidl, Jenny Stritzelberger, et al.
Neurology|July 11, 2014
Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathyYo-Tsen Liu, Matilde Laurá, Joshua Hersheson, et al.
Scientific Reports|September 1, 2023
Age of epilepsy onset as modulating factor for naming deficit after epilepsy surgery: a voxel-based lesion-symptom mapping studyCaroline Reindl, Katrin Walther, Anna-Lena Allgäuer, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic CharacterizationPiotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Molecular and Cellular Biology|October 29, 2004
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in miceL Miguel Martins, Alastair Morrison, Kristina Klupsch, et al.
Scientific Reports|June 10, 2020
Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic responseThomas A Roberts, Harpreet Hyare, Giulia Agliardi, et al.
The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
Pageof 37

Showing results (261-270 of 369) with videos related to

Sort By:
Pageof 37
Archives of Pathology & Laboratory Medicine|June 21, 2019
Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer ReportingDavid N Louis, Pieter Wesseling, Sebastian Brandner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2013
Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophyArianna Tucci, Yo-Tsen Liu, Elisabeth Preza, et al.
Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
European Journal of Neurology|September 24, 2022
Surgical hematoma evacuation of cortical intracerebral hemorrhage ≥10 ml reduces risk of subsequent epilepsy by more than 70%: A retrospective monocenter studyTamara M Welte, Josephine Steidl, Jenny Stritzelberger, et al.
Neurology|July 11, 2014
Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathyYo-Tsen Liu, Matilde Laurá, Joshua Hersheson, et al.
Scientific Reports|September 1, 2023
Age of epilepsy onset as modulating factor for naming deficit after epilepsy surgery: a voxel-based lesion-symptom mapping studyCaroline Reindl, Katrin Walther, Anna-Lena Allgäuer, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic CharacterizationPiotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Molecular and Cellular Biology|October 29, 2004
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in miceL Miguel Martins, Alastair Morrison, Kristina Klupsch, et al.
Scientific Reports|June 10, 2020
Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic responseThomas A Roberts, Harpreet Hyare, Giulia Agliardi, et al.
The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
Pageof 37